PRINAPORI, ROBERTA
 Distribuzione geografica
Continente #
EU - Europa 1.157
AS - Asia 164
NA - Nord America 57
SA - Sud America 15
AF - Africa 1
Totale 1.394
Nazione #
IT - Italia 1.133
SG - Singapore 68
US - Stati Uniti d'America 51
CN - Cina 36
VN - Vietnam 36
FR - Francia 10
BR - Brasile 9
GB - Regno Unito 6
HK - Hong Kong 5
AR - Argentina 4
IN - India 4
BD - Bangladesh 3
MX - Messico 3
CA - Canada 2
DE - Germania 2
IQ - Iraq 2
PH - Filippine 2
TR - Turchia 2
VE - Venezuela 2
DO - Repubblica Dominicana 1
DZ - Algeria 1
FI - Finlandia 1
ID - Indonesia 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
LT - Lituania 1
MD - Moldavia 1
NL - Olanda 1
NP - Nepal 1
RU - Federazione Russa 1
TH - Thailandia 1
UA - Ucraina 1
Totale 1.394
Città #
Genova 518
Genoa 389
Vado Ligure 111
Rapallo 98
Singapore 38
San Jose 25
Ho Chi Minh City 11
Hanoi 10
Lauterbourg 10
Beijing 9
Council Bluffs 8
Ashburn 6
Hong Kong 5
Haiphong 4
Rome 4
Biên Hòa 3
Bordighera 3
Guangzhou 3
Mexico City 3
Buenos Aires 2
City of London 2
Turin 2
Vicenza 2
Algiers 1
Amman 1
Amsterdam 1
Arujá 1
Açailândia 1
Baghdad 1
Basingstoke 1
Basra 1
Belford Roxo 1
Bishkek 1
Bình Dương 1
Cagayan de Oro 1
Caloocan 1
Can Tho 1
Caracas 1
Cardiff 1
Chisinau 1
Curitiba 1
Da Nang 1
Denver 1
Dhaka 1
Faridabad 1
Frankfurt am Main 1
Gresik 1
Jaú 1
Kannur 1
Kathmandu 1
Kyiv 1
Lappeenranta 1
Mannheim 1
Mar del Plata 1
Maracaibo 1
Mersin 1
Milan 1
Montanhas 1
New York 1
Newcastle upon Tyne 1
Paulista 1
Phetchaburi 1
Porto Alegre 1
Salto 1
San Benedetto del Tronto 1
San Juan 1
Santa Clara 1
Santo Domingo 1
Sejong 1
Shanghai 1
St Petersburg 1
Sunderland 1
The Bronx 1
Toronto 1
Wakefield 1
Yamuna Nagar 1
Totale 1.319
Nome #
Disseminated histoplasmosis with mucocutaneous immune reconstitution inflammatory syndrome in an HIV-infected patient 181
Predictors of retention in care for HIV-infected patients: data from San Martino Hospital cohort in Genoa 159
Predictors of retention in care in HIV-infected patients in a large hospital cohort in Italy 154
Role of HCV-RNA decay and IP-10 levels after 48 hours of standard HCV therapy as predictors of rapid virological response 152
Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial 147
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients 122
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 113
Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression: 48-week efficacy and safety results 109
The Clinical Efficacy of Multidose Oritavancin: A Systematic Review 102
Innovative Approaches to Monitor Central Line Associated Bloodstream Infections (CLABSIs) Bundle Efficacy in Intensive Care Unit (ICU): Role of Device Standardized Infection Rate (dSIR) and Standardized Utilization Ratio (SUR)—An Italian Experience 101
Decrease of renal function in HCV and HIV/HCV-infected patients with telaprevir-based therapy 97
Totale 1.437
Categoria #
all - tutte 5.153
article - articoli 4.753
book - libri 0
conference - conferenze 400
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.306


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 0 14 4 6
2021/202292 0 4 1 8 0 5 2 26 17 12 3 14
2022/2023121 10 14 0 15 12 20 0 6 20 2 18 4
2023/2024106 4 7 0 14 4 7 7 13 11 4 14 21
2024/2025263 6 24 6 16 33 30 22 63 13 9 21 20
2025/2026394 52 8 45 26 81 34 70 20 28 30 0 0
Totale 1.437